No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
EYEN240816C2500
- 0.05
- 0.000.00%
15min DelayClose Jul 22 16:00 ET
0.10High0.05Low
0.05Open0.05Pre Close13 Volume2.30K Open Interest2.50Strike Price70.00Turnover222.24%IV112.50%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1699Delta0.3600Gamma24.00Leverage Ratio-0.0035Theta0.0001Rho4.08Eff Leverage0.0008Vega
Intraday
- 5D
- Daily
News
Eyenovia Insiders Enjoying US$200k Appreciation On US$1.34m Investment
Express News | Eyenovia Shares Are Trading Higher. The Company Announced That It Commenced Activities With NovaBay Pharmaceuticals to Promote Eye Care Products to Ophthalmic Surgery Centers
Eyenovia Announces Share Offering and Warrants Sale
NovaBay and Eyenovia Begin Co-Promotion of Eyecare Products to Ophthalmic Surgery Centers
NovaBay Pharmaceuticals, Inc. (NYSE:NBY), a company developing and commercializing high-quality eyecare products, and Eyenovia, Inc. (NASDAQ:EYEN), a commercial-stage ophthalmic company with two FDA-a
Express News | Eyenovia Announces Pricing Of $5M Registered Direct Offering, Combined Offering Price For Each Share Of Common Stock And Accompanying Warrant Is $0.66
Express News | Eyenovia Prices $5M Registered Direct Offering Of 7,575,757 Shares And Warrants At $0.66 Per Share And Accompanying Warrant
Comments
$Eyenovia(EYEN.US$ Why MydCombi will be the king of cataract surgery for dilation?
These are the reasons:
1. Mydcombi will be used many times for dilation multiple patients, making it ideal for surgical settings.
2. Surgical institutions dispose of dilation medications after a single use/patient.
3. With approximately 7 million cataract surgeries performed annually in the United States. Mydcombi will help to save the potential a...
These are the reasons:
1. Mydcombi will be used many times for dilation multiple patients, making it ideal for surgical settings.
2. Surgical institutions dispose of dilation medications after a single use/patient.
3. With approximately 7 million cataract surgeries performed annually in the United States. Mydcombi will help to save the potential a...
+2
4
$Eyenovia(EYEN.US$ Imagine after launch of eyedrop the revenue forecast 😳
1st + 2nd = 2FDA
Market Value:
1st FDA Market Value: 500M
2nd FDA Market Value: 1.3B
Just only capture 5 or 10 percent.
1,800,000,000×5% = $90,000,000 M per year
1,800,000,000×10%= $180,000,000 M per year
This only 2 FDA approved
2 more FDA results coming in October or Q4 2024
and Market Value $6 B
1st + 2nd = 2FDA
Market Value:
1st FDA Market Value: 500M
2nd FDA Market Value: 1.3B
Just only capture 5 or 10 percent.
1,800,000,000×5% = $90,000,000 M per year
1,800,000,000×10%= $180,000,000 M per year
This only 2 FDA approved
2 more FDA results coming in October or Q4 2024
and Market Value $6 B
5
$Eyenovia (EYEN.US)$ They keep selling their first FDA MydCombi to Doctors office
That's why Vanguard and Insider keep buy multi million shares.
And second FDA new strongest eyedrop in the world sell starts in August
This is very good
That's why Vanguard and Insider keep buy multi million shares.
And second FDA new strongest eyedrop in the world sell starts in August
This is very good
3
$Eyenovia(EYEN.US$ For newbies, just search for "short trade." You will understand why one person always talks bad about this stock
After they short the stock
They are going to say ==> this company will be bankrupt soon, or they will say this company will do another stock offering dilution because they are shorting the stock.
Make you fear, and they make money.
They play with your emotions. Don't panic when stock goes down without no news and no reason because they are shorting.
They did ...
After they short the stock
They are going to say ==> this company will be bankrupt soon, or they will say this company will do another stock offering dilution because they are shorting the stock.
Make you fear, and they make money.
They play with your emotions. Don't panic when stock goes down without no news and no reason because they are shorting.
They did ...
5
1
$Eyenovia(EYEN.US$ First FDA helps eye doctor and surgeon to dilate eye like painting and very efficient.
The first FDA is selling in April.
The second FDA reduces time 50% and 99% pain relief and easy management for patients.
The second FDA is selling in August.
3 and 4 FDA results will be coming in Q4 2024.
CEO is talking about getting partnerships with another company to get funds more to study faster about dry eyes.
The first FDA is selling in April.
The second FDA reduces time 50% and 99% pain relief and easy management for patients.
The second FDA is selling in August.
3 and 4 FDA results will be coming in Q4 2024.
CEO is talking about getting partnerships with another company to get funds more to study faster about dry eyes.
+3
3
Read more